Dear Colleagues,
The Pain Research and Therapeutics conference brings together the leading
experts across industry and academia to discuss their findings on Pain and
cutting edge applications for drug delivery, therapeutic approaches, preclinical
and clinical development, animal models, beyond traditional opiods, and much
more. The conference will focus on the following sessions:
Sessions:
Plenary Keynote Session - Part 1
Joint Session: Overcoming Challenges in Pain Therapeutics
Joint Panel Discussion: Challenges in Developing New Therapies for Pain
Session: Preclinical and Clinical Development
Session: Novel Therapeutic Targets and Developments - Part 1
Plenary Keynote Session - Part 2
Session: New Biology and Animal Models
Session: Novel Therapeutic Targets and Developments - Part 2
To view the agenda,
click here.
To view the speaker list,
click here.
This conference is part of the
2nd CNS Diseases World Summit, which includes a total of four parallel
tracks. Gain access to all four tracks by
Registering
for the summit! Or send your team and
Register 3 for the price of 2 with the coupon code
rcdvb!
1)
6th Neurodegenerative Conditions Research and Development
2)
5th CNS Partnering and Deal-making
3)
2nd Neuropsychiatric Research and Development
4)
Pain Research and Therapeutics
We hope you can join your colleagues at this exciting and unique conference.
Best regards,
2012 Advisory Board Committee
|
What Past Delegates said:
"I thought this conference was one of the best CNS conferences of the year, with
great attendance and a wealth of presentations on many topics."
- Kees Been, CEO, EnVivo Pharmaceuticals
"The CNS Diseases Work Summit provided an excellent comprehensive overview on
current progress in the areas of psychiatry and neurology, great venue and
excellent organization helped to make this an efficient, informative and
enjoyable meeting. Great opportunities for cross company networking."
- Johan Luthman, VP Neuroscience & Ophthalmology R&D, Merck
"Scope like a small scale ICAD (International Conference of Alzheimer’s
Diseases) but much easy to digest."
- Feng Luo, M.D., Ph.D, Senior Scientist, Experimental Imaging, Abbott
Laboratories
“With high -quality presentations going on simultaneously on three separate
tracks, one of the biggest challenges for me was choosing which of them to
attend, when quite often, all three looked very worthwhile. That’s a good
problem to have. Both in terms of content and contacts, this was a very useful
conference.”
- Harry M. Tracy, PhD, President, NI Research |
|
